About

PAO Group, Inc has recently revitalized its mission to advance medical cannabis technologies with two complimenatry acquistions. One of a cannabis cultivation operation and one of a cannabis biopharmaceutical asset.

The cannabis biopharmaceutical asset, RespRx, is derived from a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING ..." With the patented intellectual property (IP), to include the existing and ongoing research and development PAOG focuses on the development of pharmaceuticals to treat various illnesses, diseases and chronic pain.

PAOG now also owns an emerging cannabis cultivator concentrating at this time on hemp cultivation within the United States and marijuana cultivation in Canada. 

Texas lawmakers have recently implemented hemp friendly farming regulations and in so doing, universities within the State of Texas have initiated hemp farming research programs. The cannabis cultivation operation has initiated a number of joint research applications with Texas universities.